piracetam has been researched along with Lung Diseases, Interstitial in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis." | 1.34 | Levetiracetam-induced diffuse interstitial lung disease. ( Castaneda, GY; Jennings, T; Newsome, SD; Xue, LY, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newsome, SD | 1 |
| Xue, LY | 1 |
| Jennings, T | 1 |
| Castaneda, GY | 1 |
1 other study available for piracetam and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Levetiracetam-induced diffuse interstitial lung disease.
Topics: Anticonvulsants; Child; Epilepsy; Female; Humans; Levetiracetam; Lung Diseases, Interstitial; Pirace | 2007 |